Assessment Of Antiviral Usage, Barriers, And Strategies For Scaling Up Hepatitis C Treatment In Malaysia: A Mix Methodology Study

Malaysia adopted three key strategies to pursue the global goal of hepatitis C elimination, namely applying compulsory licensing on a direct-acting antiviral (DAA), introducing a standard DAA-based treatment regimen (sofosbuvir and daclatasvir) and decentralizing hepatitis C care through primary hea...

Full description

Bibliographic Details
Main Author: Chan, Huan Keat
Format: Thesis
Language:English
Published: 2023
Subjects:
Online Access:http://eprints.usm.my/60514/1/Pages%20from%20CHAN%20HUAN%20KEAT%20-%20TESIS.pdf
_version_ 1811138832507076608
author Chan, Huan Keat
author_facet Chan, Huan Keat
author_sort Chan, Huan Keat
collection USM
description Malaysia adopted three key strategies to pursue the global goal of hepatitis C elimination, namely applying compulsory licensing on a direct-acting antiviral (DAA), introducing a standard DAA-based treatment regimen (sofosbuvir and daclatasvir) and decentralizing hepatitis C care through primary healthcare centers. This three-phase study adopted both quantitative and qualitative methods, aiming to (i) assess changes in the treatment coverage of individuals with hepatitis C and the government spending on antivirals after applying compulsory licensing, (ii) evaluate clinical outcomes in treatment recipients of the standard regimen, and (iii) explore barriers and potential strategies to further scale up pharmacological treatment under the existing hepatitis C care decentralization model.
first_indexed 2024-09-25T03:56:27Z
format Thesis
id usm.eprints-60514
institution Universiti Sains Malaysia
language English
last_indexed 2024-09-25T03:56:27Z
publishDate 2023
record_format dspace
spelling usm.eprints-605142024-05-02T09:47:33Z http://eprints.usm.my/60514/ Assessment Of Antiviral Usage, Barriers, And Strategies For Scaling Up Hepatitis C Treatment In Malaysia: A Mix Methodology Study Chan, Huan Keat RS1-441 Pharmacy and materia medica Malaysia adopted three key strategies to pursue the global goal of hepatitis C elimination, namely applying compulsory licensing on a direct-acting antiviral (DAA), introducing a standard DAA-based treatment regimen (sofosbuvir and daclatasvir) and decentralizing hepatitis C care through primary healthcare centers. This three-phase study adopted both quantitative and qualitative methods, aiming to (i) assess changes in the treatment coverage of individuals with hepatitis C and the government spending on antivirals after applying compulsory licensing, (ii) evaluate clinical outcomes in treatment recipients of the standard regimen, and (iii) explore barriers and potential strategies to further scale up pharmacological treatment under the existing hepatitis C care decentralization model. 2023-06 Thesis NonPeerReviewed application/pdf en http://eprints.usm.my/60514/1/Pages%20from%20CHAN%20HUAN%20KEAT%20-%20TESIS.pdf Chan, Huan Keat (2023) Assessment Of Antiviral Usage, Barriers, And Strategies For Scaling Up Hepatitis C Treatment In Malaysia: A Mix Methodology Study. PhD thesis, Universiti Sains Malaysia.
spellingShingle RS1-441 Pharmacy and materia medica
Chan, Huan Keat
Assessment Of Antiviral Usage, Barriers, And Strategies For Scaling Up Hepatitis C Treatment In Malaysia: A Mix Methodology Study
title Assessment Of Antiviral Usage, Barriers, And Strategies For Scaling Up Hepatitis C Treatment In Malaysia: A Mix Methodology Study
title_full Assessment Of Antiviral Usage, Barriers, And Strategies For Scaling Up Hepatitis C Treatment In Malaysia: A Mix Methodology Study
title_fullStr Assessment Of Antiviral Usage, Barriers, And Strategies For Scaling Up Hepatitis C Treatment In Malaysia: A Mix Methodology Study
title_full_unstemmed Assessment Of Antiviral Usage, Barriers, And Strategies For Scaling Up Hepatitis C Treatment In Malaysia: A Mix Methodology Study
title_short Assessment Of Antiviral Usage, Barriers, And Strategies For Scaling Up Hepatitis C Treatment In Malaysia: A Mix Methodology Study
title_sort assessment of antiviral usage barriers and strategies for scaling up hepatitis c treatment in malaysia a mix methodology study
topic RS1-441 Pharmacy and materia medica
url http://eprints.usm.my/60514/1/Pages%20from%20CHAN%20HUAN%20KEAT%20-%20TESIS.pdf
work_keys_str_mv AT chanhuankeat assessmentofantiviralusagebarriersandstrategiesforscalinguphepatitisctreatmentinmalaysiaamixmethodologystudy